Pyrimidinylimidazoles as tgf-beta inhibitors

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 401/14 (2006.01) A61K 31/506 (2006.01) A61P 35/00 (2006.01) C07D 403/14 (2006.01) C07D 405/14 (2006.01) C07D 471/04 (2006.01)

Patent

CA 2578630

Compounds of formula (I) possess unexpectedly high affinity for Alk 5 and/or Alk 4, and can be useful as antagonists thereof for preventing and/or treating numerous diseases, including fibrotic disorders. The invention features a compound of the general formula (I) and uses thereof.

Les composés représentés par la formule (I) possèdent de manière inattendue une haute affinité pour Alk 5 et/ou pour Alk 4 et peuvent convenir comme antagonistes de ceux-ci pour prévenir et/ou traiter de nombreuses maladies, notamment des troubles fibrotiques. Cette invention concerne les composés représentés par la formule (I) et des utilisations de ceux-ci.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Pyrimidinylimidazoles as tgf-beta inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pyrimidinylimidazoles as tgf-beta inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyrimidinylimidazoles as tgf-beta inhibitors will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1391727

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.